Meet the leaders and members of the Molecular Carcinogenesis and Chemoprevention research program at the OSUCCC – James who focus on the molecular causes and prevention of cancer.

Leaders

Steven Clinton, MD, PhD

Dr. Clinton is a physician-scientist who divides his effort between clinical care and research. He serves as director of genitourinary oncology for The James and manages the renowned Prostate Cancer Multidisciplinary Clinic.

Read More

Members

Samir Acharya, PhD

Samir Acharya, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where his research focuses on deciphering the intersection of genomic stability and cell growth/survival to develop strategies to prevent tumor growth. In particular, he explores.

Read More

Amit Agrawal, MD

Dr. Agrawal's specialty interests include head and neck oncology, facial plastic and reconstructive surgery.

Read More

Michael Bailey, PhD

Michael Bailey, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James. He brings a special perspective as an associate professor in the Division of Biosciences at The Ohio State University College of Dentistry.

Read More

Martha Belury, PhD

Dr. Belury and her lab are interested in the study of whole body energy metabolism as regulated by interactions between adipose and muscle tissues. Canonical mechanisms of energy metabolism involve insulin-dependent and –independent pathways in each of these tissues.

Read More

Don Benson, MD, PhD

Don Benson Jr. , MD PhD, FACP, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where he and his multidisciplinary, subspecialized team care for patients with multiple myeloma and amyloidosis, as well as those undergoing blood and marrow stem cell.

Read More

Richard Bruno, PhD, RD

Richard Bruno, PhD, RD, brings a unique “foods-first” perspective to the Molecular Carcinogenesis and Chemoprevention team at the OSUCCC – James, as he is based in the Human Nutrition program located in the College of Education and Human Ecology. His research uses biochemical and molecular.

Read More

Craig Burd, PhD

Craig Burd, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James. His work explores the molecular mechanisms controlling estrogen signaling and how, when not properly maintained, these mechanisms may influence breast cancer risk and therapeutic.

Read More

Moray Campbell, PhD

Moray Campbell, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where his research explores the distortion of transcription in prostate and breast cancer to improve diagnosis, prognosis and therapeutics. Specifically, he focuses on nuclear.

Read More

Tong Chen, MD, PhD

Tong Chen, MD, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James. She is a physician-scientist and believes that cancer chemoprevention is a cornerstone of cancer control.

Read More

Jessica Cooperstone, PhD

Jessica Cooperstone, Ph. D.

Read More

Christopher Coss, PhD

Christopher Coss, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where he brings a therapeutics perspective. His research focuses on cachexia therapeutics, endocrine-disease mechanisms and development of novel therapies for endocrine.

Read More

Zobeida Cruz-Monserrate, PhD

Pancreatic cancer is a deadly disease and obesity as a major risk factor. Nearly 30% of the world’s population is overweight or obese and rates continue to increase in adults and children.

Read More

Robert DiSilvestro, PhD

Phytochemicals are food components from plants that are not strictly required for normal function, but can have health promoting properties. These health promoting properties can include reducing cancer risk.

Read More

Purnima Dubey, PhD

Dr. Dubey's lab studies the effect of castration on the immune microenvironment of prostate cancer. Using endogenous murine models of prostate cancer, we showed that castration promotes the recruitment and function of suppressive neutrophils and Tregs that promote castration-resistant prostate.

Read More

William Farrar, MD

William Farrar, MD, is a surgical oncologist who serves as interim CEO of The James Cancer Hospital and Solove Research Institute and as director of the Stefanie Spielman Comprehensive Breast Cancer. Dr. Farrar has been on the medical staff at The James since the hospital opened in 1990.

Read More

Avner Friedman, PhD

Avner Friedman, PhD, is a Distinguished University Professor in the Department of Mathematics at Ohio State, where he also was the founding director of the Mathematical Biosciences Institute (MBI). As a mathematician, Dr. Friedman brings a singular perspective to his research in the Molecular.

Read More

Gayle Gordillo, MD

Gayle Gordillo, MD, is an associate professor in the Department of Plastic Surgery at Ohio State and a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where she focuses her research on the mechanisms regulating the formation of blood vessels in endothelial

Read More

Cassandra Grenade, MD

Cassandra Grenade, MD, is an assistant professor in the Division of Hematology at Ohio State and a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James. Her research focuses on cancer disparities with the intent to improve care and treatment for medically.

Read More

Earl Harrison, PhD

Earl Harrison, PhD, Dean’s Distinguished Professor in the Department of Human Sciences at Ohio State, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where his research focuses on vitamin A and its intestinal absorption, transport and metabolism.

Read More

Amanda Hummon, PhD

Dr. Hummon's research interests lie at the intersection of analytical chemistry and chemical biology, with a focus on cancer biology. Her lab develops analytical methods to evaluate the proteome, phosphoproteome and metabolome in cancer cells, while exploring the deregulation in cancer-associated.

Read More

Hisham Hussan, MD

Dr. Hussan’s research interests include studying the effect of obesity, nutrition and microbiome on gastrointestinal neoplasia in order to devise preventive measures; the underlying mechanisms for the unexplained increasing incidence of sporadic colorectal cancer in patients less than age of 50,

Read More

A. Douglas Kinghorn, PhD, DSc

A. Douglas Kinghorn, PhD, DSc, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where his current research focuses on the discovery of new anticancer agents, primarily from tropical plants.

Read More

Thomas Knobloch, MS, PhD

Thomas Knobloch, MS, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where his research focuses on molecular carcinogenesis and its interaction with food-based, cancer risk reduction strategies. In particular, his work follows a.

Read More

Somashekar Krishna, MD, MPH

Dr. Krishna's primary focus is in pancreatic malignancies. His research includes early diagnosis and diagnostic differentiation of pancreatic lesions, and specific role of endoscopic ultrasound (EUS).

Read More

Samuel Kulp, PhD

Samuel Kulp, DVM, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James. As a research scientist in The Ohio State University College of Pharmacy, Division of Medicinal Chemistry and Pharmacognosy, Dr. Kulp is part of a multidisciplinary.

Read More

Purnima Kumar, PhD, DDS

Purnima Kumar, PhD, DDS, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where her research focuses on oral bacterial profiles. In particular, Dr. Kumar is researching the role of host genetics on oral bacterial colonization and characterizing.

Read More

Pui-Kai Li, PhD

Pui-Kai Li, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where he brings a pharmacological perspective. His research explores the design, synthesis and biochemical testing of sulfatase inhibitors as possible agents in treatment of.

Read More

Young Lin, DVM, PhD

Dr. Lin's research projects are relevant to the human nutrition for chemoprevention and tumorigenesis of bio-active food component in human diets

Read More

Susan Mallery, DDS, PhD

Susan Mallery, DDS, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where her research focuses on oral pathology, oral cancer initiation and chemoprevention. She also studies AIDS-related oral cancer.

Read More

Maria Mihaylova, PhD

Dr. Mihaylova is interested in understanding the effects of diet and aging on cellular metabolism. It is now appreciated that organismal and cellular metabolism can become deregulated with age, which can potentially accelerate cancer initiation or progression.

Read More

Anjali Mishra, PhD

Anjali Mishra, PhD, is a member of the OSUCCC – James Molecular Carcinogenesis and Chemoprevention Program, where her research focuses on understanding the mechanisms of lymphomagenesis and designing therapeutic strategies for cutaneous T-cell lymphoma (CTCL). She co-holds an international.

Read More

Darrion Mitchell, MD, PhD

My over-arching interests involve improving prognostic, diagnostic, and treatment responses in head and neck cancer and prostate cancer. My initial focus will be on HPV negative head and neck cancer and the development of new selective therapy either natural or pharmacologically created that will.

Read More

Amir Mortazavi, MD

Amir Mortazavi, MD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where his research focuses on epigenetic modifications and experimental therapeutics for genitourinary cancers. One of his recent research projects suggests that sorafenib, an oral.

Read More

Tatiana Oberyszyn, PhD

Tatiana Oberyszyn, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where her research focuses on understanding the process of ultraviolet (UV) light-induced squamous cell carcinoma development. In particular, she is interested in how mediators.

Read More

Steve Oghumu, PhD

Steve Oghumu, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where his research focuses on the molecular mechanisms of oral carcinogenesis and black raspberry-mediated oral chemoprevention. He seeks to identify discrete significant mediators.

Read More

Dehua Pei, PhD

Dehua Pei, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where his research focuses on the molecular basis of biological processes by chemical methods. In particular, he seeks to identify the interaction partners of protein modular domains.

Read More

Harinantenaina Rakotondraibe, PhD

New natural product sources (new and unidentified fungal and bacterial microorganisms, plant endophytes, new endemic and medicinal plant species, etc. ) contain many undiscovered potential bioactive metabolites which can combat the world’s deadly diseases including cancer, malaria, viral.

Read More

Kenneth Riedl, PhD

Dr. Riedl is a research scientist and associate director of the Nutrient & Phytochemical Analytic Shared Resource (NPASR) of the OSU-CCC. He provides method development and analysis expertise for nutrients, phytochemicals, their metabolites, and metabolomics experiments primarily for cancer.

Read More

Kristen Roberts, PhD, RD, LD

Dr. Roberts’ research interests include biomedical research in nutrition, phytochemicals (namely ellagitannins), and cancer prevention. She has previously focused on the implementation of a black raspberry food product in men undergoing an elective prostatectomy for curative treatment of their.

Read More

Zachary Schultz, PhD

My laboratory develops instrumentation for the detection biomolecules and characterization of biological samples. We are currently funded by NCI to develop a new method for detecting changes in oncometabolites from tumors.

Read More

Daniel Spakowicz, PhD

Daniel Spakowicz, PhD, is a research assistant professor in the Division of Medical Oncology at Ohio State and a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James. His lab studies the role of the microbiome in human health, particularly the immunomodulatory.

Read More

Colleen Spees, PhD, MEd, RDN, LD, FAND

Dr. Spees is an Assistant Professor in the Division of Medical Dietetics and Health Sciences in the School of Health and Rehabilitation Sciences College of Medicine with a focus on nutrition and cancer. Her laboratory research focuses on evaluating biomarkers of nutritional and dietary.

Read More

Fred Tabung, PhD, MSPH

Fred Tabung, PhD, MSPH, is an assistant professor in the Department of Internal Medicine at Ohio State and a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where his research focuses on the role of diet and lifestyle in cancer risk and survival,

Read More

Yael Vodovotz, PhD

Dr. Vodovotz' research is focused on the physico-chemical changes of functional foods during formulation, processing and storage as they impact the delivery of bioactives. Her lab utilizes molecular, structural and macroscopic analysis to fully characterize food material behavior in different.

Read More

Qi-En Wang, PhD

Qi-En Wang, PhD, focuses his current research interests on cancer stem cell biology, DNA repair and chemotherapy resistance. He is particularly interested in investigating the DNA damage responses after cisplatin and PARP inhibitor treatment in ovarian cancer, the impact of DNA damage responses on.

Read More

Altaf Wani, PhD

Dr. Wani's research interests include Molecular carcinogenesis-analysis, fine mapping and cellular processing of specific genotoxic base lesions, mutagenesis, apoptosis and other DNA damage responses.

Read More

Christopher Weghorst, PhD

Christopher Weghorst, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at OSUCCC – James, where his work has earned him national recognition as a leader in molecular and comparative carcinogenesis research. In particular, he focuses on genetic susceptibility to.

Read More

Haitao Wen, MD, PhD

A hallmark feature of colorectal cancer (CRC) is enhanced activation of immune signaling and inflammatory cytokine production. Recent studies have established that activated immune cells and cancer cells exhibit similar reprogramming process in glucose metabolism.

Read More

Mark Wewers, MD

Dr. Wewer’s research focuses on host defense against pathogens, particularly relevant to the lung and critical to survival His lab is interested in understanding the role of proteins that regulate the activation of the intracellular enzyme, caspase-1. This work is relevant to understanding how.

Read More

Traci Wilgus, PhD

Dr. Wilgus studies the involvement of the pro-angiogenic growth factor vascular endothelial growth factor (VEGF) in skin carcinogenesis. VEGF is known to contribute to skin carcinogenesis by enhancing angiogenesis.

Read More

Kristine Yoder, PhD

DNA repair proteins are central to cancer transformation and progression. The Yoder lab is studying the interactions of host DNA repair proteins and their interactions with HIV cDNA.

Read More

Ouliana Ziouzenkova, PhD

Ouliana Ziouzenkova, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at OSUCCC – James, where her research focuses on how nutrients regulate genes and can prevent metabolic diseases. One of her recent studies highlights a mechanism by which an enzyme in vitamin A.

Read More

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program

OR

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Find a Scientific Publication

Search for Clinical Trials